West Pharmaceutical Services, Inc. (NYSE:WST) Position Reduced by Atria Investments LLC

Atria Investments LLC decreased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 4.4% during the second quarter, Holdings Channel.com reports. The firm owned 10,792 shares of the medical instruments supplier’s stock after selling 493 shares during the period. Atria Investments LLC’s holdings in West Pharmaceutical Services were worth $3,875,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of WST. FMR LLC increased its holdings in shares of West Pharmaceutical Services by 41.3% in the 1st quarter. FMR LLC now owns 794 shares of the medical instruments supplier’s stock valued at $88,000 after purchasing an additional 232 shares during the period. IFP Advisors Inc increased its holdings in shares of West Pharmaceutical Services by 34.4% in the 1st quarter. IFP Advisors Inc now owns 246 shares of the medical instruments supplier’s stock valued at $70,000 after purchasing an additional 63 shares during the period. Signaturefd LLC increased its holdings in shares of West Pharmaceutical Services by 15.3% in the 1st quarter. Signaturefd LLC now owns 340 shares of the medical instruments supplier’s stock valued at $96,000 after purchasing an additional 45 shares during the period. Daiwa Securities Group Inc. increased its holdings in shares of West Pharmaceutical Services by 4.6% in the 1st quarter. Daiwa Securities Group Inc. now owns 3,776 shares of the medical instruments supplier’s stock valued at $1,064,000 after purchasing an additional 165 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of West Pharmaceutical Services in the 1st quarter valued at about $49,000. Institutional investors own 92.74% of the company’s stock.

In other West Pharmaceutical Services news, VP Quintin J. Lai sold 9,672 shares of the stock in a transaction that occurred on Friday, September 10th. The stock was sold at an average price of $460.76, for a total transaction of $4,456,470.72. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.66% of the company’s stock.

NYSE:WST opened at $452.06 on Wednesday. The stock’s 50 day moving average price is $420.21 and its 200 day moving average price is $353.74. West Pharmaceutical Services, Inc. has a 52 week low of $253.85 and a 52 week high of $475.35. The company has a market capitalization of $33.44 billion, a P/E ratio of 66.09, a P/E/G ratio of 1.96 and a beta of 1.00. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.39 and a current ratio of 3.13.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings data on Thursday, July 29th. The medical instruments supplier reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.72. West Pharmaceutical Services had a return on equity of 28.58% and a net margin of 20.58%. The firm had revenue of $723.60 million for the quarter, compared to the consensus estimate of $665.55 million. As a group, sell-side analysts forecast that West Pharmaceutical Services, Inc. will post 8.22 earnings per share for the current fiscal year.

Separately, KeyCorp upped their target price on West Pharmaceutical Services from $350.00 to $475.00 and gave the company an “overweight” rating in a report on Friday, July 30th.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers.

See Also: How a Strangle Strategy is different from a Straddle Strategy

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.